Featured
Last news
Specificity Builds Dominant CTV Campaign Capabilities, Reinforces Position as Industry's Leading Hybrid Marketing Agency
TAMPA, FLORIDA / ACCESS Newswire / May 14, 2025 / Specificity, Inc. (OTC PINK:SPTY), the marketing industry's only true hybrid model agency, today announced the expansion of its cutting-edge Connected TV (CTV) advertising capabilities, delivering unmatched performance, precision, and value for clients looking to reach real, in-market audiences.
Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution
NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics
Fenjiu Liquor Elegance, Shared Worldwide: Asia-Pacific Cuisine Sino-Singapore Forum Successfully Concludes in Auckland
Fenjiu Shines at Asia-Pacific Culinary Forum: China-New Zealand Fusion Captivates Auckland
Coca-Cola Europacific Partners plc Announces Capital Markets Event
UXBRIDGE, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / CCEP today hosts a Capital Markets Event in Manila for analysts and investors.
Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol
Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML
UN agency finds Russia responsible for 2014 downing of airliner over Ukraine
The United Nations aviation agency has blamed Russia for the downing of a Malaysian jetliner over Ukraine in 2014, leading to the deaths of 298 people, a ruling dismissed by Moscow on Tuesday as "biased."
'I thought I was going to die,' Kardashian tells Paris robbery trial
Reality TV star Kim Kardashian told a Paris court on Tuesday she feared she would be killed by the masked men who robbed her at gunpoint of some $10 million of jewellery in her hotel room in 2016.
Sean 'Diddy' Combs' ex Cassie expected to testify
Sean "Diddy" Combs's former partner Casandra Ventura is expected to testify at his trial Tuesday with a now infamous clip of the fallen music mogul allegedly beating the singer expected to dominate questioning.
French court convicts Depardieu of sexual assault
A Paris court on Tuesday handed French cinema icon Gerard Depardieu an 18-month suspended sentence after convicting him of sexually assaulting two women on a film set in 2021.
Medical charity condemns Israel's use of hunger as 'weapon of war' in Gaza
A months-long Israeli blockade is worsening acute malnutrition in the Gaza Strip, medical charity Medecins du Monde warned on Tuesday, accusing Israel of using hunger as "a weapon of war".
Gerard Depardieu: a tarnished French film icon
Gerard Depardieu was a titan of French cinema for more than 50 years but a sexual assault conviction, a string of other allegations and several instances of lewd behaviour now cast a long, dark shadow over what was once a glittering career.
Tariffs set to level up game console prices
The US tariffs barrage and the bounding cost of producing games have prompted manufacturers like Sony and Microsoft to announce price hikes on consoles, in an industry shift experts say is set to last.
Jaded young Chinese reset lives with rural 'retirement'
Wang Dong hasn't worked for months and doesn't plan to, whiling away his days at a lakeside town as one of a growing number of young Chinese "retiring" in the countryside.
Verdict due in Depardieu sexual assault case
A Paris court is to deliver a verdict Tuesday in the sexual assault trial of French cinema icon Gerard Depardieu, in a case that has further tarnished the reputation of one of France's greatest stars.
'Unlimited power': Testimony against Sean Combs tells of lurid violence
The courtroom fell eerily silent as the footage of Sean "Diddy" Combs beating, kicking and dragging his then-girlfriend began -- a video already seen worldwide but which took on new gravity played before the jurors who will determine his future.
Angel Media Unveils Iconic New Hand-Painted Billboard in NYC’s Meatpacking District
This premium wallscape is more than just advertising - it's cultural placement. The Meatpacking District is a global destination known for its fashion-forward crowd, luxury retail, buzzing nightlife, and creative energy. This location puts brands front and center in a high-foot-traffic corridor surrounded by art galleries, tech headquarters, and trendsetting locals and tourists alike.
NHI Responds to ISS Recommendation
Urges Shareholders to Vote FOR NHI's Director Nominees on the WHITE Proxy CardStrongly Disagrees with ISS' Recommendation; Believes that it Would Put at Risk Company's Superior Shareholder Returns
Ensysce Biosciences Reports First Quarter 2025 Financial Results
Receives U.S. Patent for Groundbreaking Treatment for Opioid Use DisorderClinical Trial on Novel Analgesic, PF614-MPAR, Demonstrates Overdose Protection
Tenon Medical Reports First Quarter 2025 Financial Results
~ FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and International Patents ~~ Received Gross Proceeds of ~$7.0 Million from Equity Financing Transactions ~~ National Commercial Launch of Catamaran SE in Mid-2025 ~
Dolphin Reports Q1 2025 Results; Core Entertainment Publicity and Marketing Segment (EPM) Revenue Up 2% YoY to $12.1 Million, Strategic Investments and New Division Launch to Drive Long-Term Growth
Highlights Talent Expansion, Women's Sports Investment, Affiliate Marketing Launches, and Continued Industry RecognitionNamed 2025 Agency of the Year by Observer's PR Power List
Theranexus and Beyond Batten Disease Foundation Announce Strong Positive Real-World Data Supporting Batten-1 Efficacy for the Treatment of Batten Disease
LYON, FRANCE and AUSTIN, TX / ACCESS Newswire / May 13, 2025 / Theranexus, a biopharmaceutical company developing drug candidates for rare neurological diseases, and the Beyond Batten Disease Foundation (BBDF) today announced new real-world data strongly supporting the efficacy of Batten-1 (miglustat) as a treatment for CLN3 disease, also known as juvenile Batten disease.
CERTIFY Health Secures Growth Equity Investment from ABS Capital Partners to Accelerate Patient Engagement Innovation
New Investment Accelerates CERTIFY Health's Mission to Revolutionize Patient Engagement and Streamline Healthcare Operations
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best efforts" public offering with a single healthcare focused institutional investor for the purchase and sale of 3,952,570 shares of common stock of the Company (the "Common Stock) (or common stock equivalents in lieu thereof), at a purchase price of $1.265 per share of Common Stock. The Company further agreed to issue to the investors Series F Common Stock purchase warrants to purchase up to 3,952,570 shares of Common Stock (the "Series F Warrants"). The Series F Warrants will have an exercise price of $1.14 per share, will be exercisable immediately following the date of their issuance and will expire in five years.
Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator
LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.
Dolphin Subsidiary The Digital Dept. Sees Surge In Affiliate Marketing Division, Driving Over $6.6 Million In Gross Retail Sales In First Quarter
LOS ANGELES, CA / ACCESS Newswire / May 13, 2025 / The Digital Dept., a leading influencer marketing agency and a subsidiary of Dolphin (NASDAQ:DLPN), is celebrating rapid early success from its recently launched Affiliate Marketing and Content Creator Services division. Since its debut in January, the division has already driven more than $6.6 million in affiliate-attributed sales in the first quarter, signaling strong demand for strategic affiliate support in today's creator economy.
REMSleep Enters Formal Agreement with Major Distributor
CLEARWATER, FL / ACCESS Newswire / May 13, 2025 / REMSleep Holdings, Inc. (OTC PINK:RMSL) Enters into Formal Agreement with www.1800CPAP.com , a major DME distributor. The DeltaWave is now available nationwide.
Xebra Brands Advances Commercialization Efforts with NF Skin
Summer 2025 Launch of ELEMENTS™ CBD Product Line in United States
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that appears to cross the blood-brain barrier and has published clinical efficacy data in glioblastoma multiforme (GBM)Management releases "What This Means" segment discussing the receipt of Orphan Drug Designations for TPI 287; Access here
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Innovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care
BioNxt Reports Expanded Research, Development and Commercialization Capability with Centralized Munich Laboratory
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, is pleased to announce the integration of its research, development and commercialization activities to the Gen-Plus GmbH & Co. KG (Gen-Plus) Contract Research and Development Organization (CRDO) in Munich, Germany. The move provides BioNxt with enhanced R&D capabilities, collaboration opportunities, and accelerated innovation potential within a major European biotech hub.
Nazi files found in champagne crates in Argentine court basement
A hoard of World War II-era Nazi propaganda and membership documents has been unearthed in the basement of Argentina's Supreme Court, where it has lain, stashed in champagne crates, since 1941.
Israel urges ICC to drop arrest warrants against PM
Israel has asked the International Criminal Court to dismiss its arrest warrants against Prime Minister Benjamin Netanyahu and former defence minister Yoav Gallant while ICC judges reconsider complex jurisdictional questions.